QNCX - Quince Therapeutics, Inc.
1.27
-0.100 -7.874%
Share volume: 1,707,213
Last Updated: 04-20-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.37
-0.10
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-13-2024 | 11-13-2024 | 03-24-2025 | 05-13-2025 | 08-11-2025 | 11-12-2025 | |
| Cash flow financing | 190.000 K | 35.000 K | -5.000 M | 0.000 | 87.000 K | 14.412 M | 1.376 M | |
| Other financing cash flows | 190.000 K | 35.000 K | -5.000 M | 0.000 | 87.000 K | 2.986 M | 1.376 M | |
| Cash flow | 751.000 K | -13.682 M | -5.155 M | 0.000 | 1.384 M | 9.036 M | -10.333 M | |
| Net income | -11.149 M | -27.729 M | -5.492 M | -12.458 M | -15.030 M | -16.049 M | -13.442 M | |
| Depreciation | 40.000 K | 44.000 K | 86.000 K | 16.000 K | 32.000 K | 35.000 K | 36.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 8.914 M | -4.978 M | 7.105 M | 10.867 M | 10.898 M | 6.039 M | -1.781 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 39.000 K | 39.000 K | 46.000 K | 133.000 K | 148.000 K | 126.000 K | 74.000 K | |
| Cash Change | 1.061 M | -13.923 M | -5.215 M | 3.537 M | 1.559 M | 9.055 M | -10.374 M |